![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Allergan |
---|---|
Information provided by: | Allergan |
ClinicalTrials.gov Identifier: | NCT00621933 |
Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance of ocular isolates to commonly used topical antibiotics.
Condition |
---|
Cataract |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Culture Swabs of the conjunctiva and eyelids
Enrollment: | 399 |
Study Start Date: | December 2007 |
Study Completion Date: | November 2008 |
Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Cataract Surgery Patients
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Allergan, Inc. ( Therapeutic Area Head ) |
Study ID Numbers: | MA-Zymar-08-001 |
Study First Received: | February 13, 2008 |
Last Updated: | December 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00621933 History of Changes |
Health Authority: | United States: Institutional Review Board |
Eye Diseases Cataract Lens Diseases |
Eye Diseases Cataract Lens Diseases |